The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 06, 2016

Filed:

Feb. 12, 2015
Applicant:

Centre National DE LA Recherche Scientifique, Paris, FR;

Inventors:

Yasemin Ataman-Onal, Lyons, FR;

Thierry Delair, Echalas, FR;

Bernard Verrier, Mornant, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/00 (2006.01); C12N 15/63 (2006.01); A61K 39/39 (2006.01); A61K 39/21 (2006.01); A61K 47/48 (2006.01); A61K 39/12 (2006.01); A61K 39/235 (2006.01); A61K 39/285 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61K 47/34 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/0011 (2013.01); A61K 39/12 (2013.01); A61K 39/21 (2013.01); A61K 39/235 (2013.01); A61K 39/285 (2013.01); A61K 47/482 (2013.01); A61K 47/48792 (2013.01); A61K 47/48853 (2013.01); A61K 47/48876 (2013.01); C12N 7/00 (2013.01); A61K 39/00 (2013.01); A61K 47/34 (2013.01); A61K 2039/523 (2013.01); A61K 2039/5254 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55583 (2013.01); A61K 2039/57 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6087 (2013.01); A61K 2039/6093 (2013.01); C12N 2710/10041 (2013.01); C12N 2710/10071 (2013.01); C12N 2710/10343 (2013.01); C12N 2710/24141 (2013.01); C12N 2710/24143 (2013.01); C12N 2710/24171 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16071 (2013.01); C12N 2740/16234 (2013.01);
Abstract

A method of vaccination against a viral, bacterial or non-infectious disease includes administering an effective dose of a prime vaccine and then an effective dose of a boost vaccine. Each one of the prime vaccine and the boost vaccine includes an active principle. The prime vaccine includes, as the active principle, a colloidal synthetic bioresorbable vector that includes at least one protein substance. The boost vaccine includes, as the active principle, a viral vector that includes at least one nucleotide sequence which codes for a protein substance corresponding to the at least one protein substance of the synthetic vector.


Find Patent Forward Citations

Loading…